TREATT PLC

Director's Dealing • Mar 6, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0157S

Treatt PLC

06 March 2019

6 March 2019

TREATT PLC

("Treatt" or "the Company")

Notification of Transactions of Directors

In accordance with the requirements of the EU Market Abuse Regulation, the Company was notified that on the 5 March 2019, Tim Jones bought 11,982 ordinary shares of the Company registered in the name of Rock Nominees Ltd, at an aggregated price of £4.19.

	Details of the Director
a)	Name	Tim Jones
2	Reason for the notification
a)	Position/status	Chairman and Non-Executive Director
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Treatt Plc
b)	LEI	213800G40JM9F7G9LG39
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 2 pence each GB00BKS7YK08
b)	Nature of transaction	a)    Purchase of ordinary shares to be held in the name of Rock Nominees Ltd b)    Purchase of ordinary shares to be held in the name of Rock Nominees Ltd c)    Purchase of ordinary shares to be held in the name of Rock Nominees Ltd
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		a)    £4.19 b)    £4.19 c)    £4.19	5,933 2,609 3,440
	Aggregated information -      Aggregated volume -      Price	11,982 £4.19
e)	Date of the transaction	5 March 2019
f)	Place of the transaction	London Stock Exchange, XLON

Contact details

Anita Steer

Company Secretary

++ 44 1284 770028

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGCGDXSDGBGCL